Navigating the uncharted landscapes of drug discovery
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $6.91M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.03.2025 | Seed | $6.91M | - |
Mentions in press and media 7
| Date | Title | Description |
| 07.03.2025 | Ignota Labs: $6.9 Million (Seed) Raised For AI-Based Drug Turnaround Company | Ignota Labs, an AI-based drug turnaround company, announced the closing of a $6.9 million (GBP 5.5 million) seed funding round, co-led by Montage Ventures and AIX Ventures, with participation from Modi Ventures, Blue Wire Capital, and Gaing... |
| 28.02.2025 | Reviving the Unrevivable: Ignota Labs’ Bold Leap into Drug Development | In the world of pharmaceuticals, failure is a common companion. Over half of all clinical trials stumble and fall, leaving behind a trail of lost hope and wasted resources. This staggering reality costs the industry an estimated $400 billio... |
| 26.02.2025 | Ignota Labs raises $6.9M to rescue failing drugs with AI technology | UK pharmatech company Ignota Labs has raised $6.9 million Seed funding to advance its efforts in rescuing promising but failing drugs. Drug safety failures are a leading cause of clinical trial failures, preventing over 56 per cent of drugs... |
| 26.02.2025 | Ignota Labs Raises USD $6.9M in Seed Funding | Ignota Labs, a Cambridge, UK-based AI-driven drug turnaround company, raised USD 6.9M in Seed funding. The round was led by Montage Ventures and AIX Ventures with participation from Modi Ventures, Blue Wire Capital, and Gaingels. The compan... |
| 26.02.2025 | Rescuing drugs: Ignota Labs raises €6.6 million to turn around failed drugs | London-based Ignota Labs, an AI-driven drug turnaround company, today announced the close of a €6.6 million Seed funding round, to advance into early-stage clinical trials of their first asset, a PDE9A inhibitor. The round was co-led by Mon... |
| - | Ignota Labs | “Ignota Labs” |
| - | Ignota Labs | “Ignota Labs for in silico toxicity prediction.” |